236 related articles for article (PubMed ID: 6373929)
1. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
Biondi A; Roach JA; Schlossman SF; Todd RF
J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
[TBL] [Abstract][Full Text] [Related]
2. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
[TBL] [Abstract][Full Text] [Related]
3. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
[TBL] [Abstract][Full Text] [Related]
5. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
Lee JC; Rebar L; Young P; Ruscetti FW; Hanna N; Poste G
J Immunol; 1986 Feb; 136(4):1322-8. PubMed ID: 3003193
[TBL] [Abstract][Full Text] [Related]
7. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
[TBL] [Abstract][Full Text] [Related]
8. Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma.
Margolick JB; Ambrus JL; Volkman DJ; Fauci AS
J Immunol; 1986 Jan; 136(2):546-54. PubMed ID: 2416812
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of human thymocytes: a limiting dilution analysis of precursors with proliferative and cytolytic activities.
Lopez-Botet M; Moretta L
J Immunol; 1985 Apr; 134(4):2299-304. PubMed ID: 3919089
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms involved in T cell activation. I. Evidence for independent signal-transducing pathways in lymphokine production vs proliferation in cloned cytotoxic T lymphocytes.
Harris DT; Kozumbo WJ; Cerutti P; Cerottini JC
J Immunol; 1987 Jan; 138(2):600-5. PubMed ID: 3540123
[TBL] [Abstract][Full Text] [Related]
11. Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
Kleinerman ES; Zicht R; Sarin PS; Gallo RC; Fidler IJ
Cancer Res; 1984 Oct; 44(10):4470-5. PubMed ID: 6088039
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and functional heterogeneity of human peripheral blood T lymphocytes producing colony stimulating factor. A clonal and precursor frequency analysis.
Pantaleo G; Moretta A; Cillo C; Eliason JF; Moretta L
J Immunol; 1985 Dec; 135(6):3933-7. PubMed ID: 3877760
[TBL] [Abstract][Full Text] [Related]
13. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.
Guerne PA; Piguet PF; Vassalli P
J Immunol; 1983 May; 130(5):2225-30. PubMed ID: 6187845
[TBL] [Abstract][Full Text] [Related]
14. Cellular origin of interleukin 2 (IL 2) in man: evidence for stimulus-restricted IL 2 production by T4+ and T8+ T lymphocytes.
Meuer SC; Hussey RE; Penta AC; Fitzgerald KA; Stadler BM; Schlossman SF; Reinherz EL
J Immunol; 1982 Sep; 129(3):1076-9. PubMed ID: 6213706
[TBL] [Abstract][Full Text] [Related]
15. Preparation and antitumor effect of macrophage activating factor (MAF) encapsulated in liposomes bearing a monoclonal anti-human melanoma (A375) antibody.
Watanabe Y; Uchida E; Higuchi M; Imai Y; Osawa T
J Biol Response Mod; 1987 Oct; 6(5):556-68. PubMed ID: 3316511
[TBL] [Abstract][Full Text] [Related]
16. T-cell hybridoma production of macrophage activation factor (MAF) I. Separation of MAF from interferon gamma.
Ratliff TL; Thomasson DL; McCool RE; Catalona WJ
J Reticuloendothel Soc; 1982 May; 31(5):393-7. PubMed ID: 6181257
[TBL] [Abstract][Full Text] [Related]
17. Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor.
Kasahara T; Djeu JY; Dougherty SF; Oppenheim JJ
J Immunol; 1983 Nov; 131(5):2379-85. PubMed ID: 6195261
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
Kelso A; MacDonald HR; Smith KA; Cerottini JC; Brunner KT
J Immunol; 1984 Jun; 132(6):2932-8. PubMed ID: 6233365
[TBL] [Abstract][Full Text] [Related]
19. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
Poste G; Kirsh R; Fogler WE; Fidler IJ
Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
[TBL] [Abstract][Full Text] [Related]
20. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
